[Non surgical treatment of benign prostatic hypertrophy].
Martini
E
E
Division of Urology, S. Salvatore Hospital, L'Aquila, Italie.
Vaggi
L
L
Rucci
A
A
Di Clemente
L
L
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D047072:Aromatase Inhibitors; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D008297:Male; D008613:Mepartricin / Q000627:therapeutic use*; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000628:therapy*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists; D047072:Aromatase Inhibitors; D010936:Plant Extracts; D008613:Mepartricin